Orodispersible Tablet in Treatment of Migraine: Opportunities, Challenges and Recent Advancements
Abstract
The most comfortable and choicely path of drug administration is oral route. Orodispersible tablets bring a revolution among all routes of drug administration as well as oral route of drug administration also. Orodispersible tablets are unit dosage form but it has unique characteristics. It disintegrates in the mouth within a minute for the presence of saliva where the presence of super disintegrates in the preparation. Especially, old and child have no chance to swallow as a result it is very acceptable for them. Migraine is a very well-known irritating condition for adult and female. Migraine is a debilitating and common neurovascular illness associated with symptoms of one-sided headache, nausea with or without vomiting, photophobia and/or phonophobia. But these symptoms are subjective and vary from patient to patient. Orodispersible tablets are most important solution of migraine like emergency condition and helping human by transferring from hell to heaven. Very short half-life, quick disintegration, quick onset of action and better bioavailability brings the orodispersible tablets into the top position of the management of migraine. Sumatriptan, zolmitriptan like drugs are helping their hands to reduce migraine. Lastly, there are lots of drugs are investigating for this purpose and our hope that the orodispersible tablet can give the pioneer and will give the migraine free era to us and our futures.
Keywords: Orodispersible tablet, migraine, sumatriptan, super disintegrate, fast dissolving
Keywords:
Orodispersible tablet, migraine, sumatriptan, super disintegrate, fast dissolvingDOI
https://doi.org/10.22270/jddt.v11i4.4878References
Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery - A review. Pharm Sci Technol Today. 2000; 3(4):138-45. https://doi.org/10.1016/S1461-5347(00)00247-9
Comoglu T, Dilek Ozyilmaz E. Orally disintegrating tablets and orally disintegrating mini tablets-novel dosage forms for pediatric use. Pharm Dev Technol. 2019; 24(7):902-14. https://doi.org/10.1080/10837450.2019.1615090
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and Burden of Migraine in the United States : Data From the American Migraine Study II. 2001; 646-57. https://doi.org/10.1046/j.1526-4610.2001.041007646.x
Salomone S, Caraci F, Capasso A. Migraine: An Overview. Open Neurol J. 2009; 3(1):64-71. https://doi.org/10.2174/1874205X00903010064
Chattopadhyay S, Das S, Sarma KN. Nose-to-brain drug delivery: An update to the alternative path to successful targeted anti-migraine drugs. Int J Appl Pharm. 2021; 13(2):67-75. https://doi.org/10.22159/ijap.2021v13i2.40404
Abbas Z, Marihal S. Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: Formulation optimization using factorial design, characterization, and in vitro evaluation. J Pharm Bioallied Sci. 2014; 6(4):267-77. https://doi.org/10.4103/0975-7406.142959
Bron C, Sutherland HG, Griffiths LR. Exploring the hereditary nature of migraine. Neuropsychiatr Dis Treat. 2021; 17:1183-94. https://doi.org/10.2147/NDT.S282562
Vincent M, Wang S. The International Classification of Headache Disorders , 3rd edition. 2018; 38(1):1-211. https://doi.org/10.1177/0333102417738202
Taylor FR, Kaniecki RG. Symptomatic treatment of migraine: When to use NSAIDs, triptans, or opiates. Curr Treat Options Neurol. 2011; 13(1):15-27. https://doi.org/10.1007/s11940-010-0107-4
Siddiqui N, Garg G, Sharma PK. Fast dissolving tablets : Preparation , characterization and evaluation : An overview. Int J Pharm Sci Rev Res. 2010; 4(2):87-96.
Bandari S, Mittapalli RK, Gannu R, Rao YM. Orodispersible tablets : An overview. Asian J Pharm. 2008; 2(1):2-11. https://doi.org/10.4103/0973-8398.41557
Hannan PA, Khan JA, Khan A, Safiullah S. Oral dispersible system: A new approach in drug delivery system. Indian J Pharm Sci. 2016; 78(1):2-7. https://doi.org/10.4103/0250-474X.180244
Solanki S, Dahima R. Formulation and evaluation of aceclofenac mouth-dissolving tablet. J Adv Pharm Technol Res. 2011; 2(2):128-31. https://doi.org/10.4103/2231-4040.82951
Chawla G, Jain N. Mouth Dissolving Tablets: An Overview. 2012; 3(9):2919-25.
Shaikh S, Khirsagar R V, Quazi A. International Journal of Pharmacy and Pharmaceutical Sciences. 2010; 2(3):9-15.
Awasthi R, Sharma G, Dua K, Kulkarni GT. Fast Disintegrating Drug Delivery Systems: A Review with Special Emphasis on Fast Disintegrating Tablets. J Chronother Drug Deliv. 2013; 4(1):15-30.
Chandrasekaran G, Rajalakshmi AN. Fixed dose combination products as Oro-dispersible tablets: A review. J Drug Deliv Ther. 2019; 9(2):563-73. https://doi.org/10.22270/jddt.v9i2.2515
Khanna K, Xavier G, Joshi SK, Patel A. Fast Dissolving Tablets- A Novel Approach Fast Dissolving Tablets- A Novel Approach. . Int J Pharm Res Allied Sci. 2016; 5(2):311-22.
Kaur T, Gill B, Kumar S, Gupta GD. Mouth Dissolving Tablets: A Novel Approach To Drug Delivery. Int J Pharm Res. 2011; 3(1):1-7.
Chauhan BS, Chauhan LS, Chatterjee A, Pandey S, Baghel US. An Approach Based on Advantages over Conventional System. J Biomed Pharm Res. 2013; 2(1):41-51.
Gupta K. A, Mittal A, Jha K. K. Fast Dissolving Tablet- A Review. Pharma Innov. 2012; 1(1):1-8.
Singh S, Masih A, Kumar A, Tiwari AK. fast Dissolving Tablets Recent Advantages: A Review. Int J Curr Pharm Res. 2017; 9(2):8-18. https://doi.org/10.22159/ijcpr.2017v9i2.17382
Bhowmik D, Chiranjib B, Chandira RM. Fast Dissolving Tablet: An Overview. J Chem Pharm Res. 2009; 1(1):163-77.
Reddy CS, Cherukuri S, Komaragiri K, Priya NV, Reddipalli S . An overview of fast dissolving tablets. Int J Pharmacy&Technology. 2012; 4(2):2119-34.
Parkash V, Maan S, Deepika, Yadav S, Hemlata H, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res. 2011; 2(4):223-35. https://doi.org/10.4103/2231-4040.90877
Neeta, Dureja H, Bhagwan H, Dahiya S . Fast dissolving tablets: An overview. Nov Sci Int J Pharm Sci. 2012; 1(5):228-32.
Nagar P, Singh K, Chauhan I, Verma M, Yasir M, Khan A, et al. Orally disintegrating tablets : Formulation, preparation techniques and evaluation. J Appl Pharm Sci. 2011; 1(4):35-45.
Meyers G, Battist G, Fuisz R. Process and apparatus for making rapidly dissolving dosage units and product Thereform. PCT Patent WO 95/34293. 1995.
Shukla D, Chakraborty S, Singh S, Mishra B. Mouth dissolving tablets I: An overview of formulation technology. Sci Pharm. 2009; 77(2):309-26. https://doi.org/10.3797/scipharm.0811-09-01
Roy A. Orodispersible tablets: A review. Asian J Pharm Clin Res. 2016; 9(1):10-7. https://doi.org/10.22159/ajpcr.2017.v10i1.15439
Chowdary Y., M S, M MB, K A, P H. A Review on Fast Dissolving Drug Delivery Systems- A Pioneering Drug Delivery Technology. Bull Environ Pharmacol Life Sci. 2012; 1(12):08-20.
Pandey P, Dahiya M. Oral Disintegrating Tablets: A Review. Ijprr. 2016; 5(1):50-62.
Rahane RD RP. A Review on Fast Dissolving Tablet. J Drug Deliv Ther. 2018; 8(5):50-5. https://doi.org/10.22270/jddt.v8i5.1888
Kumar E, Bhagyashree J. Mouth Dissolving Tablets - A Comprehensive Review. Int J Pharma Res Rev. 2013; 2(7):25-41.
Gugulothu D, Desai P, Pandharipande P, Patravale V. Freeze drying: Exploring potential in development of orodispersible tablets of sumatriptan succinate. Drug Dev Ind Pharm. 2015; 41(3):398-405. https://doi.org/10.3109/03639045.2013.871551
Munija P, Srikanth G. Formulation and Evaluation of Sumatriptan Immediate Release Tablets. J Drug Deliv Ther. 2018; 8(5):241-7. https://doi.org/10.22270/jddt.v8i5.1904
Spierings ELH, Rapoport AM, Dodick DW, Charlesworth B. Acute treatment of migraine with zolmitriptan 5mg orally disintegrating tablet. CNS Drugs. 2004; 18(15):1133-41. https://doi.org/10.2165/00023210-200418150-00007
Cady RK, Martin VT, Géraud G, Rodgers A, Zhang Y, Ho AP, et al. Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response. Headache. 2009; 49(5):687-96. https://doi.org/10.1111/j.1526-4610.2009.01412.x
Dungarwal UN, Patil SB. Development of orodispersible tablets of taste masked rizatriptan benzoate using hydroxypropyl β cyclodextrin. J Pharm Investig. 2016; 46(6):537-45. https://doi.org/10.1007/s40005-016-0240-5
Alladi A, Nadu T. Formulation,Taste masking and Evaluation of Almotriptan Oral Disintegrating Tablets. Int J Pharm Sci Res. 2012; 3(10):3940-6.
Kshirasagar N, Senthil K, Sravan K, Malvey S. Formulation and Evaluation of Naratriptan Orodispersible Tablets Using Superdisintergrants by Direct Compression Method. Int J Pharm Reasearch Sch. 2013; 2(2):268-75.
Nawaj SS, Kausar SH, Khan GJ, Khan T. Formulation and Evaluation of Oral Fast Dissolving Tablet of Ondansetron Hydrochloride by Coprocess Excipients. J Drug Deliv Ther. 2017; 7(5):102-8. https://doi.org/10.22270/jddt.v7i5.1498
Draksiene G, Kopustinskiene DM, Lazauskas R, Bernatoniene J. Psyllium (Plantago ovata forsk) husk powder as a natural superdisintegrant for orodispersible formulations: A study on meloxicam tablets. Molecules. 2019; 24(18). https://doi.org/10.3390/molecules24183255
Joshi R, Garud N, Akram W. Fast Dissolving Tablets: A Review. Int J Pharm Sci Res. 2020; 11(4):1562-70.
Nirwan K, Pathan S, Agarwal T. Mouth dissolving tablets: A review. Eur J Pharm Med Res. 2020; 7(2):276-81.
Bigal ME, Walter S, Rapoport AM. Rimegepant (Nurtec ODT)for Acute Treatment of Migraine. Med Lett Drugs Ther. 2020; 324(9):1230-44. https://doi.org/10.1001/jama.2020.8493
Published
Abstract Display: 924 
PDF Downloads: 795 PDF Downloads: 200 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.